Experimental campylobacter jejuni infection in humans

Journal of Infectious Diseases

Volumn 157, Issue 3, 1988, Pages 472-479

  Black, Robert E ^a,b,c   Levine, Myron M ^a,b   Clements, Mary Lou ^a,b   Hughes, Timothy P ^a,b   Blaser, Martin J ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BLOOD CULTURE; CAMPYLOBACTER JEJUNI; DIARRHEA; EXPERIMENTAL INFECTION; FECES CULTURE; FEVER; HUMAN; IMMUNE RESPONSE; NORMAL HUMAN; SEROLOGY;

ADULT; ANTIBODIES, BACTERIAL; CAMPYLOBACTER FETUS; CAMPYLOBACTER INFECTIONS; DIARRHEA; FECES; FEVER; HUMAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023931412     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/157.3.472     Document Type: Article

References (36)

1. Butzler JP, Dekeyser P, Detrain M, Dehaen F. Related vibrioin stools. J Pediatr 1973;82:493-5.
2. Blaser MJ, Reller LB. Campylobacter enteritis. N Engl J Med 1981;305:1444-52.
3. Glass RI, Stoll BJ, Huq MI, Struelens MJ, Blaser M, Kibriya AKMG. Epidemiologic and clinical features of endemic Campylobacter jejuni infection in Bangladesh. J Infect Dis 1983;148:292-6.
4. Billingham JD. Campylobacter enteritis in The Gambia. Trans R Soc Trop Med Hyg 1981;75:641-4.
5. Glass RI, Stoll BJ, Huq MI, Struelens M, Kibriya AKMF. Family studies of Campylobacter jejuni in Bangladesh: Implications for pathogenesis and transmission. In: Pearson AD, ed. Campylobacter II. Proceedings of the Second International Workshop on Campylobacter infections. London: Public Health Laboratory System, 1983:141-42.
6. Blaser MJ. Campylobacteriosis in children: Strategies for control. In: Tzipori S, ed. Infectious diarrhea in the young: Strategies for control in humans and animals. Amsterdam: Elsevier Science Publishers, 1985:294-301.
7. Fitzgeorge RB, Baserville A, Lander KP. Experimental infection of Rhesus monkey with a human strain of Campylobacter jejuni. J Hyg (Lond) 1981;86:343-51.
8. Steele TW, McDermott S. Campylobacter enteritis in South Australia. Med J Aust 1978;2:404-6.
9. Robinson DA. Infective dose of Campylobacter jejuni in milk. Br Med J 1981;282:1584.
10. Klipstein FA, Engert RF, Short HB. Enzyme-linked immunosorbent assays for virulence properties of Campylobacter jejuni clinical isolates. J Clin Microbiol 1986; 23:1039-43.
11. Levine MM, Nalin DR, Craig JP, Hoover D, Bergquist EJ, Waterman D, Holley JP, Hornick RB, Pierce NP, Libonati JP. Immunity to cholera in man: Relative role of antibacterial versus antitoxic immunity. Trans R Soc Trop Med Hyg 1979;73:3-9.
12. Levine MM, Black RE, Clements ML, Nalin DR, Cisneros L, Finkelstein RA. Volunteer studies in development of vaccines against cholera and enterotoxigenic Escherichia coli: A review. In: Holme T, Holmgren J, Merson M, Mollby R, eds. Acute enteric infection in children: New prospects for treatment and prevention. Amsterdam: Elsevier Science Publishers, 1981: 443-59.
13. Levine MM, Black RE, Clements ML, Lanata C, Sears S, Honda T, Young CR, Finkelstein RA. Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine. Infect Immun 1984; 43:515-22.
14. Blaser MJ, Patton CM. Campylobacter enteritis associated with foodborne transmission: New serotyping data. Am J Epidemiol 1985;121:625-6.
15. Blasser MJ, Checko P, Bopp C, Bruce A, Hughes JM. Cam pylobacter enteritis associated with foodborne transmission. Am J Epidemiol 1982;116:886-94.
16. Korlath JA, Osterholm MT, Judy LA, Forfang JC, Robinson RA. A point-source outbreak of campylobacteriosis associated with consumption of raw milk. J Infect Dis 1985;152:592-6.
17. Caldwell MB, Walker RI, Stewart SD, Rogers JE. Simple adult rabbit model for Campylobacter jejuni enteritis. Infect Immun 1983;42:1176-82.
18. O’Brien AD, LaVEck GD, Thompson MR, Formal SB. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis 1982;146:763-9.
19. Perez-Perez GI, O’Brien AD, McCardell B, Cohn DL, Reller LB, Blaser MJ. Humoral response to Campylobacter jejuni cellular antigens and toxins in U.S. cases of inflammatory diarrhea. In: Proceedings of the 4th International Workshop on Campylobacter Infections. Goteborg, Sweden, 1987 (in press).
20. Blaser MJ, Perez Perez G, Smith PF, Patton C, Tenover FC, Lastovica AJ, Wang W-1L. Extraintestinal Campylobacter jejuni and Campylobacter coli infections: Host factors and strain characteristics. J Infect Dis 1986;153:552-9.
21. Brooks K, Sodeman T. Rapid detection of bacteremia by aradiometric system. Am J Clin Pathol 1974;61:859-66.
22. Bannatyne RM, Harnett N. Radiometric detection of bacteremia in neonates. Appl Microbiol 1974;27:1067-9.
23. Blaser M J, Duncan DJ. Human serum antibody response to Campylobacter jejuni as measured in an enzyme-linked immunosorbent assay. Infect Immun 1984;44:292-8.
24. Blaser MJ, Taylor DN, Echeverria P. Immune response to Campylobacter jejuni in a rural community in Thailand. J Infect Dis 1986;153:249-54.
25. Blaser MJ, Hardesty HL, Powers B, Wang WLL. Survival of Campylobacter fetus subsp. jejuni in biologic milieus. J Clin Microbiol 1980;11:309-13.
26. Riley LW, Finch MJ. Results of the first year of national surveillance of campylobacter infections in the United States. J Infect Dis 1985;151:956-9.
27. Blaser M J, Berkowitz ID, LaForce FM, Cravens J, Reller LB, Wang WLL. Campylobacter enteritis; clinical and epidemiologic features. Ann Intern Med 1979;91:179-85.
28. Klipstein FA, Engert RF, Short H, Shenk EA. Pathogenic properties of Campylobacter jejuni: Assay and correlation with clinical manifestations. Infect Immun 1985;50:43-9.
29. Caldwell MB, Guerry P, Lee EC, Burans JP, Walker RI. Reversible expression of flagella in Campylobacter jejuni. Infect Immun 1985;50:941-3.
30. Altridge SR, Rowley D. The role of the flagellum in adherence of Vibrio cholerae. J Infect Dis 1983;147:864-72.
31. Pitkanen T, Pettersson T, Ponka A. Effect of erythromycinon the fecal excretion of Campylobacter fetus subspecies jejuni. J Infect Dis 1982;145:128.
32. Blaser MJ, Sazie E, Williams LP. The influence of immunity on raw milk-associated Campylobacter infection. JAMA 1987;257:43-6.
33. Blaser MJ, Black RE, Duncan DJ, Amer J. Campylobacter jejuni-specific serum antibodies are elevated in healthy Bangladeshi children. J Clin Microbiol 1985;21:164-7.
34. Blaser MJ, Duncan DJ, Osterholm MT, Istre GR, Wang W-L. Serologic study of two clusters of infections due to Campylobacter jejuni. J Infect Dis 1983;147:820-3.
35. Levine MM, Young CR, Hughes TP, O’Donnell S, Black RE, Clements ML, Robins-Browne R, Lim Y-L. Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: Relevance for seroepidemiology. Am J Epidemiol 1981;114:348-54.
36. DuPont HL, Hornick RB, Dawkins AT, Snyder MJ, Formal SB. The response of man to virulent Shigella flexneri 2a. J Infect Dis 1969;119:296-9.